Effect of traffic pollution on respiratory and allergic disease in adults: cross-sectional and longitudinal analyses.
BACKGROUND
Epidemiological research into the role of traffic pollution on chronic respiratory and allergic disease has focused primarily on children. Studies in adults, in particular those based on objective outcomes such as bronchial hyperresponsiveness, skin sensitisation, and lung function, are limited.


METHODS
We have used an existing cohort of 2644 adults aged 18-70 living in Nottingham, UK, for whom baseline health and demographic data were collected in 1991 and computed two markers of exposure to traffic: distance between the home and nearest main road and modelled outdoor nitrogen dioxide (NO2) concentration at the home location. Using multiple regression techniques, we analysed cross-sectional associations with bronchial hyperresponsiveness, FEV1, spirometry-defined COPD, skin test positivity, total IgE and questionnaire-reported wheeze, asthma, eczema and hayfever in 2599 subjects, and longitudinal associations with decline in FEV1 in 1329 subjects followed-up nine years later in 2000.


RESULTS
There were no significant cross-sectional associations between home proximity to the roadside or NO2 level on any of the outcomes studied (adjusted OR of bronchial hyperresponsiveness in relation to living < or =150 m vs >150 m from a road = 0.92, 95% CI 0.68 to 1.24). Furthermore, neither exposure was associated with a significantly greater decline in FEV1 over time (adjusted mean difference in DeltaFEV1 for living < or =150 m vs >150 m of a road = 10.03 ml, 95% CI, -33.98 to 54.04).


CONCLUSIONS
This study found no evidence to suggest that living in close proximity to traffic is a major determinant of asthma, allergic disease or COPD in adults.
Pujades-Rodríguez
Mar
M
Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK. mar.pujades@epicentre.msf.org
McKeever
Tricia
T
Lewis
Sarah
S
Whyatt
Duncan
D
Britton
John
J
Venn
Andrea
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D000393:Air Pollutants / Q000009:adverse effects*; D001249:Asthma / Q000453:epidemiology / Q000503:physiopathology; D003430:Cross-Sectional Studies; D005260:Female; D005541:Forced Expiratory Volume / Q000502:physiology; D006801:Humans; D006967:Hypersensitivity / Q000453:epidemiology* / Q000503:physiopathology; D008137:Longitudinal Studies; D008168:Lung / Q000502:physiology; D008171:Lung Diseases / Q000453:epidemiology* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D029424:Pulmonary Disease, Chronic Obstructive / Q000453:epidemiology / Q000503:physiopathology; D012307:Risk Factors; D006113:United Kingdom; D001335:Vehicle Emissions; D055815:Young Adult
D000393:Air Pollutants; D001335:Vehicle Emissions
Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76
11316667
Am J Epidemiol. 2006 Dec 15;164(12):1190-8
17032694
Epidemiology. 2008 Sep;19(5):690-701
18703932
Am J Respir Crit Care Med. 1998 Sep;158(3):728-33
9730997
Thorax. 1983 Oct;38(10):760-5
6648855
Environ Res. 2005 Jun;98(2):240-9
15820731
Occup Environ Med. 2008 Oct;65(10):683-90
18203803
Occup Environ Med. 2005 Jun;62(6):376-80
15901884
Arch Environ Health. 1999 Jan-Feb;54(1):26-33
10025413
Lancet. 1994 Aug 6;344(8919):357-62
7914305
Occup Environ Med. 1996 Apr;53(4):241-7
8664961
N Engl J Med. 2007 Dec 6;357(23):2338-47
18057336
J Investig Allergol Clin Immunol. 2007;17 Suppl 2:3-8
18225705
Am J Respir Crit Care Med. 2002 May 1;165(9):1299-303
11991883
Epidemiology. 2003 Nov;14(6):728-36
14569190
Lancet. 2007 Feb 17;369(9561):571-7
17307103
Arch Environ Health. 1993 Jan-Feb;48(1):53-8
7680850
Epidemiology. 2005 Nov;16(6):737-43
16222162
Community Med. 1989 Nov;11(4):364-72
2634516
Epidemiology. 2000 Jul;11(4):450-6
10874554
Respir Res. 2005 Dec 22;6:152
16372913
Environ Health Perspect. 2008 Oct;116(10):1333-7
18941574
Public Health Rev. 1991-1992;19(1-4):61-72
1726935
Thorax. 2007 Oct;62(10):873-9
17442705
Occup Environ Med. 2004 Apr;61(4):350-7
15031394